Private equity and venture capitalists have increasingly focused on the acquisition of clinical trial sites, recognizing not only their operational value, but also the critical data they generate. However, most are ignorant of the complex legal and regulatory challenges they pose. Too many ignore fundamental principles and are exposed to significant fines and penalties. This article discusses some of the considerations for buyers and sellers to ensure successful and profitable transactions.
Read the full article: Acquisition of Clinical Research Sites: Key Considerations //
Source: https://www.americanbar.org/groups/business_law/resources/business-law-today/2024-september/acquisition-clinical-research-sites-key-considerations/